- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide placebo
Total 54807 results
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
Duke UniversityCelgeneTerminatedFollicular Lymphoma | Marginal Zone LymphomaUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownMyelodysplastic SyndromeIsrael
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingRelapsed/Refractory Marginal Zone LymphomaChina
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Wuerzburg University HospitalCelgene Corporation; ClinAssess GmbHActive, not recruitingPreviously Untreated Symptomatic Multiple MyelomaGermany
-
University of UlsterDSM Nutritional Products, Inc.UnknownParticipants With the MTHFR 677TT GenotypeUnited Kingdom
-
Incyte Biosciences Japan GKRecruitingDiffuse Large B-cell Lymphoma | Non Hodgkins LymphomaJapan
-
Groupe Francophone des MyelodysplasiesCelgeneCompletedLenalidomide Combined to Azacitidine in Intermediate-2 or High Risk MDS With Del 5q (GFM-AZA-REV-09)Myelodysplastic SyndromesFrance
-
Nordic MDS GroupUnknownMyelodysplastic Syndrome | Acute Myelogenous LeukemiaSweden
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Mikkael Sekeres MDNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
The Lymphoma Academic Research OrganisationRecruitingMarginal Zone LymphomaFrance
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompletedMultiple MyelomaGermany
-
Qingdao Central HospitalRecruiting
-
Ohio State University Comprehensive Cancer CenterCureTech LtdTerminatedMultiple MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterMorphoSys AGActive, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Contiguous Stage II Small Lymphocytic... and other conditionsUnited States
-
Ege UniversityCompletedSleep | AnxietyTurkey
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene; Aduro Biotech, Inc.Active, not recruitingMultiple MyelomaUnited States
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
University Hospital, LilleActive, not recruiting
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States
-
TJ Biopharma Co., Ltd.Active, not recruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseChina, Taiwan
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States
-
Fondazione Italiana Linfomi ONLUSCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Childhood Choroid Plexus Tumor | Childhood Craniopharyngioma | Childhood Ependymoblastoma | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood Grade III Meningioma | Childhood High-grade Cerebellar Astrocytoma and other conditionsUnited States
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Shaoxing Second Hospital; Huizhou Municipal Central... and other collaboratorsRecruiting
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneCompletedChronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupRoche Pharma AG; Celgene; Mundipharma Research GmbH & Co KGCompletedChronic Lymphocytic LeukemiaGermany
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Celgene CorporationTerminatedChronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
UMC UtrechtCelgene CorporationCompletedMultiple MyelomaNetherlands
-
Cristina GasparettoCelgene CorporationCompletedMultiple MyelomaUnited States